Shizuoka, Japan

Emi Shimoike

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Corporation, Kyowa Hakko Kirin Co., Limited. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emi Shimoike. Retrieved from https://idiyas.com/inventor/emi-shimoike

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emi Shimoike: Innovator in Therapeutic Agents

Introduction

Emi Shimoike is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of medicine, particularly in the development of therapeutic agents. Her innovative work has led to the creation of a patent that addresses a critical health issue.

Latest Patents

Emi Shimoike holds a patent for a therapeutic agent for restenosis. This agent comprises a thiadiazoline derivative represented by a specific general formula, or a pharmaceutically acceptable salt thereof. The invention aims to provide a therapeutic and/or prophylactic solution for restenosis, which is a condition that can occur after vascular interventions.

Career Highlights

Throughout her career, Emi has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Fujifilm Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Emi has collaborated with esteemed colleagues, including Ryuichiro Nakai and Hideaki Kusaka. These partnerships have fostered an environment of innovation and have led to advancements in therapeutic solutions.

Conclusion

Emi Shimoike's contributions to the field of therapeutic agents highlight her role as a leading inventor. Her patent for a therapeutic agent for restenosis showcases her commitment to improving health outcomes. Through her work and collaborations, she continues to make a significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…